Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2Â
A drug that is commonly used to treat tapeworm infections might help to prevent the formation of atypical fused cells in the lungs of patients with COVID-19, according to laboratory experiments reported this week in Nature.
Apr 8, 2021
0
7
